US Federal 2025-2026 Regular Session

US Federal House Bill HB1616

Introduced
 
Introduced
2/26/25  

Caption

Promoting Access to Diabetic Shoes Act

Summary

HB1616, titled the Promoting Access to Diabetic Shoes Act, would amend the Medicare statute to allow nurse practitioners and physician assistants, in addition to physicians, to satisfy the documentation requirement for coverage of certain therapeutic shoes for people with diabetes. Under current law, Medicare coverage for these shoes depends on documentation from a physician; this bill broadens the set of qualified clinicians who can provide the required certification. The bill is narrowly targeted and does not create a new benefit so much as it changes who may complete the paperwork needed to access an existing Medicare-covered item. Its practical effect would be to reduce administrative barriers for beneficiaries with diabetes, especially in settings where nurse practitioners and physician assistants are the primary clinicians managing care. The bill would amend Section 1861(s)(12) of the Social Security Act, which governs Medicare coverage of diabetic shoes and related documentation requirements.

Impact

If enacted, the bill would revise Medicare coverage rules in Title XVIII of the Social Security Act by expanding the list of authorized practitioners who can meet the documentation requirement for diabetic shoe coverage. This would affect Medicare beneficiaries with diabetes, as well as physicians, nurse practitioners, physician assistants, and suppliers involved in certifying and dispensing therapeutic shoes. The change is limited to documentation authority and would not alter eligibility for the shoes themselves or broader Medicare benefits.

Sentiment

The available context suggests generally positive, low-conflict sentiment around the bill. There are no recorded committee transcripts or votes indicating opposition, and the measure appears to be a bipartisan access-oriented proposal introduced by members from both parties. The framing of the bill as improving access to medically necessary diabetic footwear suggests support from advocates for diabetes care and primary care access.

Contention

No specific points of contention are documented in the provided materials. Potential areas of debate, if any arise, would likely concern Medicare program integrity, whether non-physician practitioners should be allowed to satisfy documentation requirements, and whether the change could affect oversight or supplier billing practices. However, the bill text itself is limited and the available record does not show organized opposition or disputed provisions.

Companion Bills

US SB1805

Same As Promoting Access to Diabetic Shoes Act

Previously Filed As

US SB1805

Promoting Access to Diabetic Shoes Act

US HB1370

Nurse practitioners; authorize to prescribe therapeutic shoes for persons with diabetes.

US HB1317

I CAN Act Improving Care and Access to Nurses Act

US SB575

I CAN Act Improving Care and Access to Nurses Act

US SB4070

Diabetes Foot Health Access and Modernization Act of 2026

US HB7905

Diabetes Foot Health Access and Modernization Act of 2026

US HB1167

To Modify The Signature Authority For Advanced Practice Registered Nurses And Physician Assistants; And To Clarify That Durable Medical Equipment Includes Diabetic Shoes And Shoe Inserts.

US HB3826

Expanding Access to Diabetes Self-Management Training Act of 2025

US SB1925

Expanding Access to Diabetes Self-Management Training Act of 2025

US SB4037

Diabetes Act Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services (DIABETES) Act

Similar Bills

No similar bills found.